China's demand for cardiovascular drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1995, 2000 and 2005) and long-term forecasts throught 2010 and 2015 are presented. Major producers in China are profiled.
Content
I. Introduction
Report Scope and Methodology
Executive Summary
II. Business Environment
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
II. Cardiovascular Drugs Industry Assessments
Cardiovascular Drugs Industry Structure
Market Size
Major Producer Facility Locations and Output
Market Share of Key Producers
Labor Costs
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development
IV. Cardiovascular Drugs Outputs And Forecasts
Overview
Western Cardiovascular Drugs Production and Demand
Western Cardiovascular Drugs Introduction
Major Producers
Foreign Trade
Total Output and Demand
Pricing Trends
Output and Demand for Kinds of Cardiovascular Diseases
Drugs for Cardiac Insufficiency
Antiarrhythmic Drugs
Antianginal Drugs
Antihyperlipidemia Drugs
Antihypertensive Drugs
Peripheral Angiolencs
Antishock Drugs
The Others
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Chinese Traditional Cardiovascular Drugs Production & Demand
Chinese Traditional Cardiovascular Drugs Introduction
Major Producers
Foreign Trade
Total Output and Demand
Pricing Trends
Production and Demand for Kinds of Cardiovascular Diseases Treatment
Drugs for Cardiac Insufficiency
Antiarrhythmic Drugs
Antianginal Drugs
Antihyperlipidemia Drugs
Antihypertensive Drugs
Peripheral Angiolencs
Antishock Drugs
The Others
Output and Demand by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
V. Cardiovascular Drugs Market Outlooks
Cardiovascular Drugs Markets Outlook Overview
Government Cardiovascular Drugs Regulations
Health Care Insurance Industry Overview
China's Health Care and Cardiovascular Disease Treatment Overview
Treatment revenues
Hospitals
Physicians
China's Population Overview
Population by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Population by Age Group
China's Cardiovascular Diseases Patients Overview
China's Cardiovascular Diseases Patients by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
China's Cardiovascular Diseases Patients by Age Group
Cardiovascular Diseases Patients Spending Trends
VI. Marketing Strategies
Distribution System in China
China's Distribution System
The Pharmaceuticals Distribution Channels
Transportation and Freight Infrastructure
Communications
Market Entry Channels
Exporting to China
Export Market Overview
Chinese Trading Practice
Trading Companies
Import Restrictions in China
Technology Licensing
Technology Licensing Overview
Intellectual Property Protection
Joint Venture
Joint Venture Overview
Advantages and Disadvantages
Wholly Owned Enterprises
Foreign Wholly Owned Enterprises Overview
Advantages and Disadvantages
Other Market Entry Channels
Setting up Sales Offices
Selling to China Through Attending Trade Fairs
Contacting Chinese Companies
Advertising
Market Entry Strategies
Understanding Differences
Business Practice Differences
Knowledge of Regulations and Restrictions
Dealing with Governments
VI. Cardiovascular Drugs Producers Profiles And Directory
Western Cardiovascular Drugs Producers Profiles
Chinese Traditional Cardiovascular Drugs Producers Profiles